Fate Therapeutics (FATE) Issued U.S. Patent No. 9,452,186 Covering Enhanced Hematopoietic Stem Cell Compositions
Tweet Send to a Friend
Fate Therapeutics, Inc. (NASDAQ: FATE) announced today that the U.S. Patent and Trademark Office issued U.S. Patent No. 9,452,186 covering ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE